Skip to main content
Premium Trial:

Request an Annual Quote

Sequencing Cancer

Dan Koboldt blogs about WashU's recent kickoff party for its Cancer Genomics Initiative. The center's goal is to sequence 150 cancer genomes in one year. They'll be looking at AML some more — they published on AML genomes in Nature last fall and this month in the New England Journal of Medicine — as well as breast cancer, lung cancer, glioblastoma multiforme, and ovarian cancer. Koboldt adds that he's heard rumors that they'll also tackle rarer cancers such as multiple myeloma. "As Tim Ley said yesterday, it's thrilling to be a part of this. We truly are entering the golden age of cancer genomics," Koboldt blogs.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.